1. Home
  2. CPSS vs SLS Comparison

CPSS vs SLS Comparison

Compare CPSS & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consumer Portfolio Services Inc.

CPSS

Consumer Portfolio Services Inc.

N/A

Current Price

$8.33

Market Cap

189.3M

Sector

Finance

ML Signal

N/A

Logo SELLAS Life Sciences Group Inc.

SLS

SELLAS Life Sciences Group Inc.

HOLD

Current Price

$3.77

Market Cap

208.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPSS
SLS
Founded
1991
2012
Country
US
US
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
189.3M
208.0M
IPO Year
2010
2007

Fundamental Metrics

Financial Performance
Metric
CPSS
SLS
Price
$8.33
$3.77
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
14.3K
4.7M
Earning Date
01-01-0001
04-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
62.69
EPS
0.59
N/A
Revenue
$393,506,000.00
N/A
Revenue This Year
$139.62
N/A
Revenue Next Year
$10.58
N/A
P/E Ratio
$14.13
N/A
Revenue Growth
11.79
N/A
52 Week Low
$6.67
$0.95
52 Week High
$11.42
$5.18

Technical Indicators

Market Signals
Indicator
CPSS
SLS
Relative Strength Index (RSI) 42.56 50.92
Support Level $8.27 $3.46
Resistance Level $9.20 $3.90
Average True Range (ATR) 0.26 0.28
MACD -0.02 -0.07
Stochastic Oscillator 6.89 42.18

Price Performance

Historical Comparison
CPSS
SLS

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Share on Social Networks: